News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi: TIGERMED CONSULTING Fundamentals Unaffected; Share Price Weakness Seen as Entry Pt
TIGERMED (03347.HK) disclosed that its co-founders and controlling shareholders, Ye Xiaoping and Cao Xiaochun, received formal case filing notices from the China Securities Regulat...
Reset
Send
The window will close in 5 seconds
<Research>Citi: TIGERMED CONSULTING Fundamentals Unaffected; Share Price Weakness Seen as Entry Pt
Close
Recommend
4
Positive
4
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Gold ETF share!

TIGERMED (03347.HK)  -0.680 (-1.864%)    Short selling $8.67M; Ratio 10.357%   disclosed that its co-founders and controlling shareholders, Ye Xiaoping and Cao Xiaochun, received formal case filing notices from the China Securities Regulatory Commission for failing to promptly disclose equity changes after their shareholding ratios fell by more than 10 ppts between December 2014 and May 2026, Citi said in a research report.

Citi believed this constitutes a compliance procedural violation, with the most likely resolution being a warning and fine, pending clarification of penalties. The broker believed the incident has no impact on the company's fundamentals and viewed any share price weakness as an enhanced buying opportunity.

Related NewsNomura: TIGERMED (03347.HK) Directors and Controlling Shareholders Placed Under Investigation, Expects Short-term Share Price Pressure
The broker assigned TIGERMED CONSULTING (300347.SZ)  -1.200 (-2.502%)   an A-share TP of RMB67 and maintained a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-15 16:25.) (A Shares quote is delayed for at least 15 mins.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.